Locations:
Search IconSearch
January 5, 2018/Cancer/Patient Support

Fear of Recurrence Common Among Breast Cancer Survivors

Providers can help prevent or minimize the trauma

counseling_650x450

Earlier identification and better treatment of breast cancer has resulted in 3.1 million survivors of the disease in the U.S. alone. While that’s good news, success is producing an ever-growing number of women who suffer from an unwanted long-term side effect of this achievement: fear of recurrence, which can be paralyzing.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Fear of recurrence is very common in breast cancer survivors. Half of all survivors experience some fear, but in 20-50 percent, the fear is clinically significant and profoundly affects their lives,” says Kathleen Ashton, PhD, a psychologist in Cleveland Clinic’s Breast Center.

Irrational worries

Fear of recurrence has little to do with the patient’s true risk and does not diminish over time. Instead, it tends to remains stable and often grows.

“Sometimes these fears start the day the patient is diagnosed, before she’s had any treatment. More typically, however, they occur when treatment is ending and the patient will no longer be seen as often,” says Dr. Ashton.

Without the safety of regular contact with a medical team, fears start creeping in.

“Treatment consumes your life. You are doing something every day to beat your cancer. When your treatment ends, you are no longer doing things to actively treat your cancer,” she says. “You also have more time to worry. You start wondering, will it come back? Will it progress? Will I die?”

Not surprisingly, women with a history of anxiety or depression prior to their cancer diagnosis are at greater risk of experiencing these fears.

“Waiting for the other shoe to fall”

Women who fear a recurrence of their disease are often perplexed by their inability to feel happy. “They think, ‘I’m cancer-free. Why am I not feeling great?’” says Dr. Ashton.

Family members, friends and even providers often don’t understand these negative emotional side effects, intensifying feelings of loneliness. “There is pressure to feel like you are back to normal,” she says.

Advertisement

As time passes, pervasive worry, anxiety and sense of “waiting for the other shoe to fall” may become overwhelming. Patients become consumed with fears about the potential physical problems associated with a cancer recurrence, such as pain, treatment discomfort and death. They wonder how their illness will affect their family, and dwell on landmark occasions, such as graduations and weddings, they might miss.

“It’s not unusual for these patients to develop checking behaviors, like pain, headache or feeling sick, that drive them to the emergency department thinking their cancer has come back,” says Dr. Ashton.

How providers can help

Dr. Ashton recommends providers not wait for a patient to raise the issue of recurrence, but rather, start the conversation early. She suggests asking patients:

  1. Do you worry about your cancer coming back?
  2. Do you worry about it progressing?
  3. Is worry affecting your daily life or the ability to sleep?

Worry may be diffused or prevented by taking the following steps:

  1. Provide real recurrence rates based on the patient’s individual condition.
  2. Create a survivorship follow-up plan that includes a timetable for surveillance and follow-up appointments.
  3. Remind the patient about what has been done to manage the cancer and reduce risk.

“Tell her how much her risk was reduced by surgery, by chemotherapy, by radiation and by any selective estrogen receptor modulator (SERM) or aromatase inhibitor she will continue to take. Don’t forget to reinforce the benefits of a healthy lifestyle going forward,” says Dr. Ashton.

Advertisement

Sometimes, however, logic and facts are not enough to dispel fear. When this happens, intervention is needed.

“If you see a clinically significant issue, refer the patient to mental health professional, such as a psychologist, for cognitive behavioral therapy or other evidence-based treatment,” Dr. Ashton advises.

Advertisement

Related Articles

Dr. Angelini
December 24, 2025/Cancer/News & Insight
Study Analyzes Direct Oral Anticoagulants Use in Patients with Brain Metastases

Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population

Lobular breast cancer cells
December 22, 2025/Cancer/Innovations
Comprehensive Lobular Breast Cancer Program Addresses Often-Misunderstood Disease

Care paths and research initiatives aim to answer unmet clinical needs

Dr. Singh
December 19, 2025/Cancer/Blood Cancers
IDH1 Inhibitor Found Safe and Effective in Rare Precursor to Blood Malignancies

Study shows high rate of hematologic responses, low rate of disease progression

Shahzad Raza, MD
December 18, 2025/Cancer/Blood Cancers
Talquetamab Provides Lifesaving Bridge to CAR T-Cell Therapy

Bispecific antibody bridging therapy deepens durability of BCMA CAR T-cell therapy without overlapping toxicities in patients with relapsed/refractory multiple myeloma

Dr. Raza
December 16, 2025/Cancer/Blood Cancers
Dual Bispecifics May Redefine Management of Extramedullary Myeloma

Phase 2 study brings pivotal advances in treatment efficacy and safety for the most challenging-to-treat population

CAR T-cell therapy
December 15, 2025/Cancer/Blood Cancers
Case Study: Patient Remains Disease Free Five Years After Allogenic CAR T-Cell Therapy

Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy

J. Joseph Melenhorst, PhD
December 12, 2025/Cancer/Blood Cancers
Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma

Distinct baseline immune profiles can predict response and resistance to different types of CAR-T cells.

church bus tour
December 9, 2025/Cancer/News & Insight
Novel Community Campaign Increases Venous Thromboembolism Awareness

National Blood Clot Alliance collaborates with faith-based organizations on first-of-its-kind church bus tour

Ad